Larynx, hypopharynx
Showing 1 - 25 of 619
Head Neck Cancer Trial in Shijiazhuang (Delineation for organs at risks (OARs) in IMRT plan)
Not yet recruiting
- Head and Neck Cancer
- Delineation for organs at risks (OARs) in IMRT plan
-
Shijiazhuang, Hebei, ChinaDepartment of Radiotherapy, Hebei Province Hospital of Chinese M
Sep 9, 2022
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
HNSCC, Head Neck Cancer, Oropharynx Cancer Trial in Groningen (blood draws)
Recruiting
- HNSCC
- +4 more
- blood draws
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
Laryngeal Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in
Not yet recruiting
- Laryngeal Squamous Cell Carcinoma
- +2 more
- Sentinel lymph node biopsy guided selective elective neck irradiation
- Standard elective neck irradiation
-
Amsterdam, Netherlands
- +5 more
Aug 30, 2022
Oral Cavity Cancer, Oropharynx Cancer, Hypopharynx Cancer Trial in Tampa (ENHANCE Intervention)
Recruiting
- Oral Cavity Cancer
- +3 more
- ENHANCE Intervention
-
Tampa, FloridaMoffitt Cancer Center
Apr 4, 2023
Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx Trial in Rotterdam (CRGD-ZW800-1)
Not yet recruiting
- Squamous Cell Carcinoma of the Larynx
- Squamous Cell Carcinoma of the Hypopharynx
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Feb 21, 2023
Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- +3 more
- Eliminating RT to the elective neck
- RT standard of care
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023
Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Tumors Trial in Shanghai (chemo TP regimen combined with Toripalimab)
Recruiting
- Laryngeal Cancer
- +2 more
- chemotherapy TP regimen combined with Toripalimab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 2, 2022
Malignant Tumor of Oropharynx Stage III, Malignant Tumor of Larynx Stage III, Malignant Tumor of Hypopharynx Stage III Trial in
Recruiting
- Malignant Neoplasm of Oropharynx Stage III
- +7 more
- Escalated Dose
- Standard Dose
-
Kolkata, West Bengal, IndiaTata Medical Centre
Dec 2, 2021
HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in
Not yet recruiting
- HPV-Related Squamous Cell Carcinoma
- +4 more
- Cisplatin
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023
Head Neck Cancer Trial in San Diego (Medpulser Electroporation with Bleomycin, Surgical Excision)
Terminated
- Head Neck Cancer
- Medpulser Electroporation with Bleomycin
- Surgical Excision
-
San Diego, CaliforniaInovio Biomedical Corporation
Mar 2, 2022
Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)
Withdrawn
- Head and Neck Squamous Cell Carcinoma
- +4 more
- (no location specified)
Aug 1, 2022
Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Copenhagen (Liquid biopsy)
Recruiting
- Head and Neck Cancer
- +26 more
- Liquid biopsy
-
Copenhagen, Region Hovedstaden, DenmarkUniversity Hospital of Copenhagen, Rigshospitalet
Sep 14, 2021
Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Winston-Salem (Pembrolizumab,
Recruiting
- Head Neck Cancer
- +5 more
- Pembrolizumab
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Health Sciences
Aug 8, 2022
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville
Not yet recruiting
- Head and Neck Cancer
- +9 more
- Zimberelimab
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 9, 2022
Oropharynx Squamous Cell Carcinoma, Larynx Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma Trial in Brussels
Recruiting
- Oropharynx Squamous Cell Carcinoma
- +3 more
- IO102
- IO103
-
Brussels, BelgiumCliniques Universitaires Saint-Luc
May 6, 2022
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity
Active, not recruiting
- Squamous Cell Carcinoma of the Oropharynx
- +7 more
-
Tampa, Florida
- +2 more
Dec 30, 2022
Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,
Completed
- Hypopharynx Squamous Cell Carcinoma
- +2 more
- AZD1775
- +2 more
-
Birmingham, West Midlands, United Kingdom
- +5 more
Nov 9, 2022
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- cetuximab
- +3 more
-
Newark, New JerseyNew Jersey Medical School
Apr 19, 2021
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- +9 more
- Carboplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
The Voice asTool to Detect Recurrence of Laryngeal and
Not yet recruiting
- Laryngeal Cancer
- Hypopharyngeal Cancer
- Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire
-
Bern, SwitzerlandDepartment of Oto-Rhino-Laryngology, Head and Neck Surgery, Inse
May 30, 2023
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Stage II-IVB Operable HNSCC Oral Cavity, Hypopharynx, Oropharynx Trial in Seoul (Durvalumab, durvalumab + tremelimumab)
Recruiting
- Stage II-IVB Operable HNSCC Oral Cavity
- +3 more
- Durvalumab
- durvalumab + tremelimumab
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Apr 22, 2021